Costa Rica gets $9 million cancer screening equipment:
This article was originally published in Clinica
Executive Summary
Costa Rica is to receive from Japan equipment worth $9 million to improve early detection of stomach cancer. It is hoped that early radiography and endoscopy screening will help achieve the over 90% cure rate seen in Japan, reports the BMJ. Costa Rica has an incidence of 52 per 100,000 population (1998), with an 86% five-year mortality rate.
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.